OR WAIT null SECS
TransPerfect, a provider of e-clinical technologies to the life sciences industry, announced that INC Research, a therapeutically focused clinical research organization (CRO), has selected Trial Interactive as its global electronic Trial Master File (eTMF) solution. Trial Interactive is a secure, web-based platform that reduces the redundancies inherent in paper-based TMF management.
"We chose Trial Interactive as our eTMF solution because it offers the greatest compatibility with current and potential customers,” said Todd Esporas, Executive Director of Clinical Development Services at INC Research. As one of the top 10 global CROs, optimizing the collection and management of TMFs worldwide is a critical task for INC Research. Trial Interactive enables INC Research to deliver trials more efficiently by allowing real-time access to global project documentation, eliminating much of the travel and shipping associated with TMF reviews and reconciliation, and providing a real-time metrics dashboard to enhance communications with customers and stakeholders. Trial Interactive’s interface is available in more than 20 languages, which will enable INC Research to deploy the solution in the local language of the end user, making it ideal for global study teams, sponsors, and investigative site personnel involved in the conduct of multinational clinical trials.
Michael Smyth, General Manager of TransPerfect’s Life Science Solutions division, stated, “We’re very proud that INC Research has chosen Trial Interactive as its eTMF solution. INC’s global reach and commitment to utilizing technology should only serve to benefit their study sponsors as they seek to become more efficient in conducting global clinical trials.”